Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63365	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
62711	And it's down big time, LOL. I guess results were not significant. I think	kdd999	1	7/31/2024
62710	simufilam OL time zero data tells the whole story...been mentioned here before,	scorman1	4	7/31/2024
62709	From ClinicalTrials.gov on CASA's OL trial (the boldface and underline is fr	weatherproof	1	7/30/2024
62708	I did pick up a few shares of CASA a couple weeks ago at $9.81, but wishing I bo	weatherproof	2	7/30/2024
62707	Cassava Sciences Announces Expansion of Open-Label Extension Trials Of course,	erickerickson	4	7/30/2024
62706	Cognition Therapeutics announces positive results from trial of oral treatment f	erippetoe	-	7/29/2024
62705	Sysiphus - Here are my thoughts on that article: The headline includes the use	weatherproof	1	7/29/2024
62704	finance.yahoo.com	sysiphus	-	7/29/2024
62703	Results from AVXL ph 2b/3 AD trial: anavex.com	weatherproof	2	7/29/2024
62702	Stew, my read is that they're going for AA and part of that equation is to a	weatherproof	1	7/26/2024
62701	from Aug 2023 conf call With newly available preliminary efficacy results of s	scorman1	1	7/26/2024
62700	>>Biogen Inc. TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) -	weatherproof	1	7/26/2024
62699	>> the company has clearly stated that a new FDA phase 3 is required, s	weatherproof	2	7/26/2024
62698	on AVXL: When EF Hutton speaks.....they should get their facts straight in the f	scorman1	4	7/25/2024
62697	investing.com	sysiphus	1	7/25/2024
62696	AVXL has already announced they will need a full phase 3, 1 1/2yr trial for AD,	scorman1	1	7/25/2024
62695	FWIW - AVXL was $3.70 in June and broke $7 earlier today. It's catching up	weatherproof	2	7/25/2024
62694	Simufilam treatments will be extended to patients who have completed extension t	scorman1	5	7/24/2024
62693	I was previously unaware of the connection between SAVA chairman Rick Barry and	Olecranon	2	7/22/2024
62692	ex_701112.htm (sec.gov)	sukit	5	7/22/2024
62691	The Western blot "purporting to show Drug A's mechanism of action"	ghettogoulash	3	7/21/2024
62690	End of the day, moving on from Remi and his bride was the right thing to do. Ei	allatwwk	2	7/18/2024
62689	A quick update, Mike called this afternoon, he didn’t get much sleep the first 3	idahoranch1	26	7/18/2024
62688	My biggest issue with my SAVA position was Barbier. His quarterly calls made him	sukit	-	7/18/2024
62687	IN RE CASSAVA SCIENCES INC. 2020 CASH INCENTIVE PLAN DERIVATIVE LITIGATION ----	erickerickson	4	7/18/2024

Go to reply# or date (mm/dd/yy):